•CAStar is a leading manufacturer in synthetic biology, specializing in the research and production of bioactive and functional human proteins. The company is led by a visionary founding team with expertise in microbiology, mycology, glycobiology, and food science.
•CAStar's core technology involves using Kluyveromyces marxianus yeast as a chassis cell for genetic engineering to express and secrete glycosylated exogenous proteins. The company employs high-throughput screening to obtain high-expression cell strains for large-scale precision fermentation. Their focus is on producing glycoproteins similar to human milk proteins, which offer immune, antibacterial, and antioxidant benefits. CAStar has developed portfolios of expression vectors and chassis cells, enabling rapid selection for genetic editing to express desired proteins.
CAStar
现时募资阶段:
A轮
投资年份:
2024 - HK GBA Fund
类别:
AI/Synthetic biology
创办人:
Yu Tian, Dr. Cheng Jin
创立年份:
2021